FMED vs. XLV
Compare and contrast key facts about Fidelity Disruptive Medicine ETF (FMED) and Health Care Select Sector SPDR Fund (XLV).
FMED and XLV are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. FMED is an actively managed fund by Fidelity. It was launched on Apr 16, 2020. XLV is a passively managed fund by State Street that tracks the performance of the Health Care Select Sector. It was launched on Dec 16, 1998.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: FMED or XLV.
Correlation
The correlation between FMED and XLV is 0.70, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Performance
FMED vs. XLV - Performance Comparison
Key characteristics
FMED:
0.48
XLV:
0.45
FMED:
0.75
XLV:
0.69
FMED:
1.09
XLV:
1.09
FMED:
0.87
XLV:
0.38
FMED:
1.93
XLV:
1.29
FMED:
3.83%
XLV:
3.81%
FMED:
15.49%
XLV:
10.88%
FMED:
-21.84%
XLV:
-39.17%
FMED:
-4.91%
XLV:
-11.03%
Returns By Period
In the year-to-date period, FMED achieves a 4.36% return, which is significantly higher than XLV's 3.35% return.
FMED
4.36%
-0.67%
5.26%
7.37%
N/A
N/A
XLV
3.35%
-3.32%
-4.89%
4.39%
8.01%
9.00%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
FMED vs. XLV - Expense Ratio Comparison
FMED has a 0.50% expense ratio, which is higher than XLV's 0.12% expense ratio.
Risk-Adjusted Performance
FMED vs. XLV - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Fidelity Disruptive Medicine ETF (FMED) and Health Care Select Sector SPDR Fund (XLV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
FMED vs. XLV - Dividend Comparison
FMED's dividend yield for the trailing twelve months is around 0.45%, less than XLV's 1.65% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FMED Fidelity Disruptive Medicine ETF | 0.45% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
XLV Health Care Select Sector SPDR Fund | 1.65% | 1.59% | 1.47% | 1.33% | 1.49% | 2.17% | 1.58% | 1.47% | 1.60% | 1.43% | 1.35% | 1.52% |
Drawdowns
FMED vs. XLV - Drawdown Comparison
The maximum FMED drawdown since its inception was -21.84%, smaller than the maximum XLV drawdown of -39.17%. Use the drawdown chart below to compare losses from any high point for FMED and XLV. For additional features, visit the drawdowns tool.
Volatility
FMED vs. XLV - Volatility Comparison
Fidelity Disruptive Medicine ETF (FMED) has a higher volatility of 5.22% compared to Health Care Select Sector SPDR Fund (XLV) at 3.51%. This indicates that FMED's price experiences larger fluctuations and is considered to be riskier than XLV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.